- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-696/19: Judgment of the General Court of 8 July 2020 — Teva Pharmaceutical Industries v EUIPO (Moins de migraine pour vivre mieux) (EU trade mark — Application for EU word mark Moins de migraine pour vivre mieux — Absolute ground for refusal — No distinctive character — Article 7(1)(b) of Regulation (EU) 2017/1001)
ECLI:EU:UNKNOWN:62019TA0696
62019TA0696
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
12.10.2020
Official Journal of the European Union
C 339/19
(Case T-696/19) (*)
(EU trade mark - Application for EU word mark Moins de migraine pour vivre mieux - Absolute ground for refusal - No distinctive character - Article 7(1)(b) of Regulation (EU) 2017/1001)
(2020/C 339/24)
Language of the case: English
Parties
Applicant: Teva Pharmaceutical Industries Ltd (Petah Tikva, Israel) (represented by: J. Bogatz and Y. Stone, lawyers)
Defendant: European Union Intellectual Property Office (represented by: L. Rampini and V. Ruzek, acting as Agents)
Re:
Action brought against the decision of the Fifth Board of Appeal of EUIPO of 12 August 2019 (Case R 778/2019-5), relating to an application for registration of the word sign Moins de migraine pour vivre mieux as an EU trade mark.
Operative part of the judgment
The Court:
1.Dismisses the action;
2.Orders Teva Pharmaceutical Industries Ltd to pay the costs.
(*)
Language of the case: English.
(1) OJ C 413, 9.12.2019.